| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |